Navigation Links
23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire
Date:6/25/2013

n)[9]

Différentes bithérapies antihypertensives peuvent être utilisées dans la pratique clinique. Cependant, des études ont mis en évidence une efficacité particulière pour les traitements associant un diurétique avec un inhibiteur de l'enzyme de conversion (IEC), un antagoniste des récepteurs de l'angiotensine (ARA II), ou un inhibiteur calcique. Des études récentes à grande échelle ont aussi mis en évidence une efficacité particulière pour l'association d'un IEC et d'un inhibiteur calcique. L'association d'un antagoniste des récepteurs de l'angiotensine et d'un inhibiteur calcique semble aussi être rationnelle et efficace.

Chez au moins 15 à 20% des patients hypertendus, la pression artérielle n'est pas contrôlée par une bithérapie. Lorsque trois médicaments sont nécessaires, l'association la plus optimale semble être un bloqueur du système rénine-angiotensine associé à un inhibiteur calcique et à un diurétique à doses efficaces.[9]

A propos de Daiichi Sankyo

Le Groupe Daiichi Sankyo s'est donné pour mission de créer et fournir des produits pharmaceutiques innovants pour répondre aux divers besoins médicaux non satisfaits des patients dans les marchés matures et émergents. Tout en maintenant son portefeuille de médicaments commercialisés pour traiter l'hypertension, l'hyperlipidémie, et les maladies infectieuses, le Groupe se concentre aussi sur le développement de traitements pour les maladies thrombotiques, et sur la découverte de traitements originaux dans les domaines de l'oncologie et des pathologies cardiovasculaires et métaboliques. Par ailleurs, le Groupe Daiichi Sankyo a créé un "Modèle Économique Hybride" afin de r&#
'/>"/>

SOURCE Daiichi Sankyo Europe GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
2. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
3. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. ETEX Corporation to present at the 9th World Biomaterial Congress
8. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
9. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
10. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
11. BIOCOM Announces Endorsement in 52nd Congressional District Race
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... JOSE, California , January 15, 2014 ... cancer, today announced the appointment of Thomas C Reynolds MD, ... 20 years, development experience gained in the biotechnology industry, most ... "I am delighted to welcome Tom at this transformative time ...
(Date:1/15/2014)... A study has been launched to test whether ... could help to tackle the problem of obesity.  This unique ... surgery based in Stowmarket) and academics at University Campus Suffolk ... technology, which is inspired by equipment used to collect data ...
(Date:1/15/2014)... 15, 2014 The Microcompetition with Foreign DNA ... One of these latent viruses is the Epstein Barr Virus ... Rheumatoid arthritis (RA) is a chronic inflammatory disease that destroys ... found that RA patients have high concentrations of EBV DNA ...
(Date:1/15/2014)... Freeslate, Inc ., the leading ... Lupin Limited, one of India’s top five pharmaceutical companies, ... System for high throughput solid form screening. ... a wide range of quality, affordable generic and branded ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3
... at the 2008 Genitourinary Cancers Symposium, ... Inc. announced,today that the Company,s lead cancer ... was well-tolerated in combination with either docetaxel ... with,hormone refractory prostate cancer. Additionally, patients treated ...
... to household cleaners will benefit from new technologies and ... the National Institutes of Health (NIH) and the U.S. ... toxicity testing agreement. The concept behind this agreement is ... journal Science. , Two NIH institutes have formed ...
... 10 a.m.A summary of the National Nanotechnology Initiative (NNI) ... Nanoscale Science, Engineering, and Technology (NSET) Subcommittee of the ... report is a supplement to the Presidents Budget for ... budget request, as well as highlights of planned activities ...
Cached Biology Technology:OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 2OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 3OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer 4NIH collaborates with EPA to improve the safety testing of chemicals 2NIH collaborates with EPA to improve the safety testing of chemicals 3National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights 2
(Date:4/17/2014)... Razzari of the nergie Matriaux Tlcommunications Research Centre ... John R. Evans Leaders Fund of the Canada ... state-of-the-art biotech and nanophotonics equipment. To this funding ... de l,Enseignement suprieur, de la Recherche, de la ... laboratories will help us develop new approaches for ...
(Date:4/17/2014)... Our eyes not ... with a continuous stream of information about our own movements. ... a car the world glides by us and leaves ... our brain calculates self-motion from this "optic flow". This way, ... during our own movements. Together with biologists from the University ...
(Date:4/17/2014)... eight years ago, Katia Silvera , a postdoctoral scholar ... on a field trip in a mountainous area in central ... seen before. , Unable to identify it, they contacted German ... out to be an unnamed species. So Carnevali recently named ... is the genus name, comprising about 40 species in the ...
Breaking Biology News(10 mins):New state-of-the-art biotech and nanotech equipment for INRS 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3
... this week in The Lancet Infectious Diseases ... bacterial infection that causes pneumonia, meningitis and sepsis ... a blood disorder prevalent in African children that increases ... study underscores the critical need for use of pneumococcal ...
... Could one of South America,s greatest military figures ... tuberculosis assumed at the time of his death in ... known as "El Libertador" or "The Liberator" ... Historical Clinicopathological Conference (CPC), sponsored by the University of ...
... 2010) Eighty percent of health problems and five million ... water and sanitation according to the World Water Development Report ... for rural villagers, highlights a dire need for reliable access ... aims to solve. The Lemelson-MIT Program today announced ...
Cached Biology News:Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 2Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 3Historic medical conference finds Bolivar may have been poisoned 2Historic medical conference finds Bolivar may have been poisoned 3Historic medical conference finds Bolivar may have been poisoned 4Inventor honored for tech improving access to clean water, healthcare, and business development in India 2Inventor honored for tech improving access to clean water, healthcare, and business development in India 3Inventor honored for tech improving access to clean water, healthcare, and business development in India 4
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: Western Blot...
... (MUC3) is a glycoprotein. distributed in ... extent in breast, lung and salivary gland ... cross-reaction with MUC1 and MUC2. ... Immunogen: MUC3 tandem repeat peptide ...
... caudal-related homeobox family, is an intestine-specific transcription ... in intestinal epithelial cells. It plays an ... phenotype of differentiated villus enterocytes as well ... Clone CDX2-88 reacts with a conserved epitope ...
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Biology Products: